AzTrials
AzTrials

SuicideNCT07111052

Lock and Protect: Reducing Adolescent Access to Lethal Means of Suicide

A study testing Lock and Protect is a self-administered, web-based decision aid for caregivers of adolescents at risk for suicide. in people with Suicide and Suicide Attempt, run by Columbia University at 1 site in United States.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

The primary goal is to determine the acceptability and feasibility of implementing the Lock and Protect decision aid. The secondary goals are to identify the potential short-term impact of Lock and Protect on home firearm and medication storage, parental self-efficacy. Read more about this study

Who is it for?
Ages 13 to 17 years
Conditions the study is for
Suicide, Suicide Attempt, Adolescent Suicidality
What is being tested?
Lock and Protect is a self-administered, web-based decision aid for caregivers of adolescents at risk for suicide.
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteUnited States
Study dates
11 Sep 2025to Mar 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

None listed.

Who cannot join

  • Medically unstable children
  • Patients with autism, intellectual disability, or active psychosis
  • Lack of parental and/or youth English and/or Spanish fluency
  • Caregivers who do not reside in the same home as the patient for at least 2 nights a week
  • If the caregiver OR patient does not agree to participation both participants will be excluded

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site
  • Morgan Stanley Children's Hospital, Pediatric Emergency

    New York, New York, 10032

Other trials in United States

About this study

Official title: Lock and Protect: An Emergency Department Randomized Controlled Trial to Reduce Adolescent Access to Lethal Means of Suicide

The primary goal is to determine the acceptability and feasibility of implementing the Lock and Protect decision aid. The secondary goals are to identify the potential short-term impact of Lock and Protect on home firearm and medication storage, parental self-efficacy. Using interviews with caregivers, the study will clarify the acceptability, feasibility, and barriers to implementing the Lock and Protect hone safety plan. This will allow further development of effective strategies to subsequently further test and use Lock and Protect in the ED.

NOTE: The study will only recruit guardians and their adolescents from the pediatric ED at Morgan Stanley Children's Hospital NY-Presbyterian.

Read the detailed description

Suicide is the second leading cause of death in adolescents in the United States. Suicide rates increased 22% from 2005-2015, with a 28% increase in New York State. Emergency Departments (EDs) capture a medically underserved population at high risk for suicide and provide an important but typically missed opportunity for adolescent suicide prevention. Reducing access to guns, medications, and other methods of suicide (also called lethal means restriction or counseling) is one of the few suicide prevention interventions found to decrease suicides. It is based on the idea that reducing access to highly lethal means of suicide during a time of vulnerability can prevent suicide by decreasing the lethality of attempts. This is of critical importance in adolescence, when the transition from thinking about suicide to committing or attempting suicide is often sudden and unplanned, using the most readily available method to attempt suicide. However, effective tools to facilitate suicide prevention, particularly restricting lethal mean access, are lacking. Our expert team has developed a novel, low-resource, tablet-based intervention termed Lock and Protect intended to decrease risk of suicide in adolescents evaluated in EDs.

The investigator will conduct a research study of parents or caregivers (hereafter referred to as caregivers) who receive the intervention during evaluation of their adolescent in the ED for suicidal ideation, self-ham, or suicide. The study will randomly assign caregivers; those who are assigned to the intervention will receive usual ED care and receive the Lock and Protect intervention. Guardians randomly assigned to receive usual ED care alone will complete study surveys in addition to usual ED care. Usual ED care for patients presenting with self-harm or suicidal thoughts and behaviors includes evaluation by the child psychiatry team and determination of risk to determine if safety planning (Stanley Brown safety plan completed in the medical chart), discharge home, or inpatient psychiatric admission is warranted. The study will enroll parents of youths 13-17 years-old presenting to the ED for suicidal thoughts or behaviors. Caregivers will not be part of the study if their child is medically unstable, a caregiver does not speak English or Spanish, and/or they do not reside in the same home as the patient. The investigator hopes to determine if home access to high-risk medications and/or firearms has changed at 1-month after ED visit. The study will also measure decision quality and behavioral intent through surveys.

Being tested
Lock and Protect is a self-administered, web-based decision aid for caregivers of adolescents at risk for suicide.
Keywords
adolescent suicide, lethal means counseling, lethal means access, adolescent suicide prevention
Medical subject headings
Suicide, Suicide, Attempted

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lock and Protect is a self-administered, web-based decision aid for caregivers of adolescents at risk for suicide.Behavioural

    Lock and Protect is a user-friendly web-based decision aid that identifies preferences and explores options for removing or storing lethal means safety through: (a) education on home means of suicide, such as firearms, medications, and other potentially dangerous home and external items/situations (e.g., poisons, methods/ligatures used in suffocation/hanging), and community hazards (e.g., subways, heights); (b) safe storage options; and (c) protective monitoring and supervision as a means of increasing adolescent safety during a time of elevated risk.

Study groups in NCT07111052
Study groupRoleWhat they receive
Lock and Protect, web-based lethal means counseling interventionExperimentalGuardians and patients will receive the intervention, Lock and Protect, is a user-friendly web-based decision aid that identifies preferences and explores options for removing or storing lethal means safety.
Receives: Behavioral: Lock and Protect is a self-administered, web-based decision aid for caregivers of adolescents at risk for suicide.
Usual careNo interventionAll patients enrolled in the study, as part of usual care, will receive evaluation by the pediatric psychiatry team. This includes in-depth interviews about suicide risk and self-harm. All patients enrolled in this study are 1) evaluated by the pediatric psychiatry team and 2) evaluated for safety and suicide risk that informs if inpatient behavioral health admission is warranted based on the assessment. All patients who are eligible for study enrollment, as part of usual care for patients presenting for suicidal thoughts and behaviors or self-harm, will receive standard safety procedures while undergoing evaluation in the ED. These ED specific safety procedures include clinical observation of the patient while deemed to be at risk for any form of self-harm, removal of any phones and/or personal items that may be used for self-harm, being placed in behavioral health specific ED evaluation rooms, and (when warranted) security team presence.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of caregivers who improved home storage of medications and/or firearms

    The primary efficacy outcome is change in home access to medications and/or firearms by 1-month post-discharge from the ED, as measured by a REDCap self-administered survey.

    Measured: Baseline (ED visit), 1 month follow-up

Secondary outcomes (4)
  1. Mean Decision Conflict Scale Score (low literacy)

    This outcome is designed to measure decision quality. Decision quality is a fundamental element of the Ottawa Decision Support Framework, as a marker of readiness to change. Scores range from 0 (no decisional conflict) to 100 (extremely high decisional conflict).

    Measured: Baseline (ED visit)

  2. Number of subsequent ED visits for suicide-related events

    The study will assess subsequent adolescent ED visits for NSSI, suicidal ideation, or suicide attempt, within 3 months of baseline ED visit.

    Measured: From ED enrollment to 3-months after baseline ED visit

  3. Feasibility of Intervention Measure - Instrument Score

    This is to measure feasibility of intervention. A 4-item instrument measuring the feasibility of an intervention. Reported by caregivers, assigned to the intervention arm, after completion of the Lock and Protect intervention.

    Score response range 1-5. Completely disagree (1) Disagree (2) Neither agree nor disagree (3) Agree (4) Completely agree (5)

    Scale is created by averaging the 4 responses.

    Measured: Baseline (ED visit)

  4. Acceptability of Intervention: Instrument score

    This is to measure acceptability of intervention. A 4-item instrument measuring the acceptability of an intervention. Completed by caregivers assigned to the intervention, after completing the Lock and Protect intervention.

    Score response range 1-5. Completely disagree (1) Disagree (2) Neither agree nor disagree (3) Agree (4) Completely agree (5)

    Scale is created by averaging the 4 responses.

    Measured: Baseline (ED visit)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Aug 2025
  2. Study start11 Sep 2025
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completionMar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07111052
Sponsor's protocol ID
AAAV6627
Status last verified
Dec 2025
First submitted
6 Aug 2025
Last updated
5 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Lock and Protect is a self-administered, web-based decision aid for caregivers of adolescents at risk for suicide. in people with Suicide and Suicide Attempt, run by Columbia University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 5 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of caregivers who improved home storage of medications and/or firearms (time frame: Baseline (ED visit), 1 month follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Dec 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in